Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of dexmedetomidine hydrochloride microneedle patch for preoperative sedation in adults
CTR20260725Phase 2Active
- Sponsor
- Xinji Pharma
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in preoperative anxiety, sponsored by Xinji Pharma. Started Mar 2026; status: active.
02
Drugs
dexmedetomidine
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on CTR20260725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260725.